J&J arthritis drug goes up against Humira, with mixed results

(Reuters) – Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc’s top-selling Humira in a large trial.

<img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=m6zri42uozY:EVVS_unt2iE:V_&#8230;
To learn more visit: Reuters: Health News

The post J&J arthritis drug goes up against Humira, with mixed results appeared first on Online Medical Assistant Training Programs.

J&J arthritis drug goes up against Humira, with mixed results

from WordPress https://onlinemedicalassistantprogramsedu.wordpress.com/2016/11/13/jj-arthritis-drug-goes-up-against-humira-with-mixed-results/